vs
Side-by-side financial comparison of GE HealthCare (GEHC) and IMPERIAL OIL LTD (IMO). Click either name above to swap in a different company.
IMPERIAL OIL LTD is the larger business by last-quarter revenue ($8.2B vs $5.7B, roughly 1.4× GE HealthCare). GE HealthCare runs the higher net margin — 10.3% vs 4.4%, a 6.0% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.1% vs -10.5%). Over the past eight quarters, GE HealthCare's revenue compounded faster (10.7% CAGR vs -4.2%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Imperial Oil Limited is a Canadian petroleum company. It is Canada's second-largest integrated oil company that is also occasionally known as Imperial Esso. It is majority-owned by American oil company ExxonMobil, with a 69.6% ownership stake in the company. It is a producer of crude oil, diluted bitumen, and natural gas. Imperial Oil is one of Canada's major petroleum refiners and petrochemical producers. It supplies Esso-brand service stations.
GEHC vs IMO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.7B | $8.2B |
| Net Profit | $588.0M | $359.2M |
| Gross Margin | 39.7% | — |
| Operating Margin | 14.5% | 5.6% |
| Net Margin | 10.3% | 4.4% |
| Revenue YoY | 7.1% | -10.5% |
| Net Profit YoY | -18.4% | -59.8% |
| EPS (diluted) | $1.28 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.7B | $8.2B | ||
| Q3 25 | $5.1B | $8.8B | ||
| Q2 25 | $5.0B | $8.2B | ||
| Q1 25 | $4.8B | $9.1B | ||
| Q4 24 | $5.3B | $9.2B | ||
| Q3 24 | $4.9B | $9.7B | ||
| Q2 24 | $4.8B | $9.8B | ||
| Q1 24 | $4.7B | $9.0B |
| Q4 25 | $588.0M | $359.2M | ||
| Q3 25 | $446.0M | $393.5M | ||
| Q2 25 | $486.0M | $692.8M | ||
| Q1 25 | $564.0M | $940.2M | ||
| Q4 24 | $721.0M | $894.3M | ||
| Q3 24 | $470.0M | $903.0M | ||
| Q2 24 | $428.0M | $827.1M | ||
| Q1 24 | $374.0M | $872.4M |
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — | ||
| Q1 24 | 40.9% | — |
| Q4 25 | 14.5% | 5.6% | ||
| Q3 25 | 12.7% | 5.8% | ||
| Q2 25 | 13.1% | 11.1% | ||
| Q1 25 | 13.2% | 13.5% | ||
| Q4 24 | 15.1% | 12.5% | ||
| Q3 24 | 13.9% | 12.1% | ||
| Q2 24 | 12.6% | 11.1% | ||
| Q1 24 | 11.6% | 12.8% |
| Q4 25 | 10.3% | 4.4% | ||
| Q3 25 | 8.7% | 4.5% | ||
| Q2 25 | 9.7% | 8.4% | ||
| Q1 25 | 11.8% | 10.3% | ||
| Q4 24 | 13.6% | 9.7% | ||
| Q3 24 | 9.7% | 9.3% | ||
| Q2 24 | 8.8% | 8.5% | ||
| Q1 24 | 8.0% | 9.7% |
| Q4 25 | $1.28 | — | ||
| Q3 25 | $0.98 | — | ||
| Q2 25 | $1.06 | — | ||
| Q1 25 | $1.23 | — | ||
| Q4 24 | $1.58 | — | ||
| Q3 24 | $1.02 | — | ||
| Q2 24 | $0.93 | — | ||
| Q1 24 | $0.81 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $833.7M |
| Total DebtLower is stronger | $10.0B | $2.9B |
| Stockholders' EquityBook value | $10.4B | $16.2B |
| Total Assets | $36.9B | $30.9B |
| Debt / EquityLower = less leverage | 0.96× | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.5B | $833.7M | ||
| Q3 25 | $4.0B | $1.4B | ||
| Q2 25 | $3.7B | $1.7B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.9B | $714.7M | ||
| Q3 24 | $3.5B | $1.1B | ||
| Q2 24 | $2.0B | $1.5B | ||
| Q1 24 | $2.6B | $858.5M |
| Q4 25 | $10.0B | $2.9B | ||
| Q3 25 | $10.3B | $2.9B | ||
| Q2 25 | $10.3B | $2.9B | ||
| Q1 25 | $8.8B | $2.9B | ||
| Q4 24 | $9.0B | $2.9B | ||
| Q3 24 | $10.3B | $2.9B | ||
| Q2 24 | $9.2B | $2.9B | ||
| Q1 24 | $9.3B | $2.9B |
| Q4 25 | $10.4B | $16.2B | ||
| Q3 25 | $10.0B | $17.3B | ||
| Q2 25 | $9.7B | $18.2B | ||
| Q1 25 | $9.2B | $17.8B | ||
| Q4 24 | $8.4B | $17.1B | ||
| Q3 24 | $8.3B | $17.3B | ||
| Q2 24 | $7.8B | $17.5B | ||
| Q1 24 | $7.4B | $16.9B |
| Q4 25 | $36.9B | $30.9B | ||
| Q3 25 | $36.1B | $31.4B | ||
| Q2 25 | $35.5B | $32.2B | ||
| Q1 25 | $33.6B | $32.0B | ||
| Q4 24 | $33.1B | $31.3B | ||
| Q3 24 | $33.9B | $31.0B | ||
| Q2 24 | $31.9B | $32.2B | ||
| Q1 24 | $32.2B | $31.0B |
| Q4 25 | 0.96× | 0.18× | ||
| Q3 25 | 1.03× | 0.17× | ||
| Q2 25 | 1.06× | 0.16× | ||
| Q1 25 | 0.95× | 0.16× | ||
| Q4 24 | 1.06× | 0.17× | ||
| Q3 24 | 1.24× | 0.17× | ||
| Q2 24 | 1.18× | 0.17× | ||
| Q1 24 | 1.25× | 0.17× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.4B |
| Free Cash FlowOCF − Capex | — | $938.8M |
| FCF MarginFCF / Revenue | — | 11.4% |
| Capex IntensityCapex / Revenue | 2.4% | 5.6% |
| Cash ConversionOCF / Net Profit | — | 3.90× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $94.0M | $1.1B | ||
| Q1 25 | $250.0M | $1.1B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $-119.0M | $1.2B | ||
| Q1 24 | $419.0M | $785.5M |
| Q4 25 | — | $938.8M | ||
| Q3 25 | — | $944.6M | ||
| Q2 25 | $8.0M | $725.6M | ||
| Q1 25 | $98.0M | $824.2M | ||
| Q4 24 | — | $997.2M | ||
| Q3 24 | — | $730.7M | ||
| Q2 24 | $-183.0M | $852.6M | ||
| Q1 24 | $274.0M | $422.7M |
| Q4 25 | — | 11.4% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | 0.2% | 8.8% | ||
| Q1 25 | 2.1% | 9.0% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | 7.5% | ||
| Q2 24 | -3.8% | 8.7% | ||
| Q1 24 | 5.9% | 4.7% |
| Q4 25 | 2.4% | 5.6% | ||
| Q3 25 | 2.1% | 4.2% | ||
| Q2 25 | 1.7% | 4.2% | ||
| Q1 25 | 3.2% | 3.2% | ||
| Q4 24 | 1.9% | 3.4% | ||
| Q3 24 | 1.9% | 3.7% | ||
| Q2 24 | 1.3% | 3.4% | ||
| Q1 24 | 3.1% | 4.0% |
| Q4 25 | — | 3.90× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | 0.19× | 1.54× | ||
| Q1 25 | 0.44× | 1.19× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | -0.28× | 1.44× | ||
| Q1 24 | 1.12× | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
IMO
Segment breakdown not available.
